Mineralys Therapeutics MLYS
NASDAQ MLYS
$23.63 -0.09 (-0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mineralys Therapeutics (MLYS) Invested Capital (2025 - 2026)

Updated

Mineralys Therapeutics (MLYS) reported Invested Capital of $648.53 million for Q2 2026.

Analysis

Mineralys Therapeutics (MLYS) Invested Capital (2025 - 2026) Analysis & Trends

For FY2025, Mineralys Therapeutics posted Invested Capital of $646.69 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Mineralys Therapeutics 2.22 Bn 2.22 Bn - 648.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 648.53 Mn
Dec 31, 2025 646.69 Mn
API Access

Mineralys Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=MLYS&period=max&api_key=YOUR_API_KEY